Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 7.81B | 6.69B | 6.73B | 6.79B | 6.69B |
Gross Profit | 682.48M | 552.31M | 659.23M | 575.68M | 459.76M |
EBITDA | 226.98M | 193.36M | 211.00M | 288.80M | 96.28M |
Net Income | 67.09M | 49.64M | 68.19M | 150.43M | -41.56M |
Balance Sheet | |||||
Total Assets | 5.73B | 4.85B | 4.74B | 5.11B | 5.05B |
Cash, Cash Equivalents and Short-Term Investments | 905.59M | 742.58M | 934.31M | 650.75M | 570.57M |
Total Debt | 2.31B | 1.38B | 1.35B | 1.76B | 2.29B |
Total Liabilities | 4.22B | 3.35B | 3.20B | 3.63B | 3.77B |
Stockholders Equity | 1.51B | 1.51B | 1.54B | 1.48B | 1.28B |
Cash Flow | |||||
Free Cash Flow | -623.19M | -285.56M | 750.49M | 656.70M | 34.59M |
Operating Cash Flow | -463.32M | -237.30M | 813.44M | 677.19M | 50.00M |
Investing Cash Flow | -148.43M | -26.21M | -20.28M | 15.52M | -49.28M |
Financing Cash Flow | 791.25M | 25.95M | -517.72M | -627.56M | -170.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $205.73B | 7.42 | 9.66% | 5.03% | 9.97% | -19.80% | |
73 Outperform | $132.21B | 17.19 | 6.62% | 4.73% | -16.64% | 1.10% | |
69 Neutral | HK$82.81B | 21.78 | 2.17% | 6.41% | -30.38% | -43.73% | |
67 Neutral | HK$148.85B | 8.78 | 4.15% | 2.11% | -10.21% | -40.22% | |
61 Neutral | HK$337.30M | 6.72 | -6.86% | 6.58% | 22.80% | -18.34% | |
58 Neutral | HK$13.96B | 4.77 | -2.71% | 5.86% | 3.74% | -52.98% | |
55 Neutral | $68.30B | ― | -2.30% | 1.74% | -36.07% | -441.20% |